NCT07438327

Brief Summary

This study will test how well an artificial intelligence (AI) software called Aorta AIM measures the size of the aorta (the body's main blood vessel) from CT scans. The aorta can become enlarged over time, which may lead to serious health problems. Doctors need to measure the aorta accurately to monitor patients and decide on treatment. Currently, doctors measure the aorta manually on CT scans, which takes time and can vary between different doctors. Aorta AIM is designed to measure the aorta automatically and consistently. In this study, researchers will compare Aorta AIM's measurements to those made by experienced radiologists or cardiologists (doctors who specialize in reading medical images). The study will use CT scans that have already been taken as part of routine medical care - no additional scans or procedures are needed. The study will include approximately 250 participants across multiple hospitals in Brazil and the United States. Participants will be adults who have had a chest or abdominal CT scan that shows their aorta. The main goals are to:

  • Check if Aorta AIM measures the aorta as accurately as radiologists
  • See if Aorta AIM can help doctors work more efficiently
  • Evaluate if the software works well in different hospital settings and with different types of patients This research may help improve how doctors monitor aortic disease and make treatment decisions in the future. There are no risks to participants since the study only uses existing medical images.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
2 countries

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Feb 2026Sep 2026

Study Start

First participant enrolled

February 2, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2026

Expected
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

February 23, 2026

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Absolute Error (MAE) between Aorta AIM measurements and expert reference standard

    Mean Absolute Error (MAE) between aortic diameter measurements generated by Aorta AIM version 1.0 and the reference standard established by board-certified or equivalently experienced expert radiologists performing manual annotations. MAE will be calculated across all anatomical regions of the aorta assessed in the study.

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

Secondary Outcomes (5)

  • Bland-Altman Limits of Agreement

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

  • Intraclass Correlation Coefficient (ICC)

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

  • Processing success rate

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

  • Processing time

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

  • Qualitative clinical acceptability scores by expert readers

    At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)

Study Arms (1)

Validation Cohort

Adults who have undergone chest or abdominal CT imaging (with or without contrast) as part of routine clinical care. CT scans will be retrospectively collected and processed by both Aorta AIM software and expert radiologists to validate automated aortic diameter measurements.

Diagnostic Test: Aorta AIM Automated MeasurementDiagnostic Test: Expert Radiologist Manual Measurement

Interventions

Manual aortic diameter measurements performed by experienced radiologists (minimum 5 years of cardiovascular imaging experience) using standard clinical measurement techniques on the same CT scans analyzed by Aorta AIM software. These measurements serve as the reference standard for validation.

Validation Cohort

Aorta AIM is an investigational artificial intelligence software that automatically measures aortic diameters from CT imaging. The software analyzes retrospectively collected CT scans and generates standardized aortic diameter measurements at anatomically defined locations. These automated measurements will be compared to manual measurements performed by expert radiologists.

Also known as: Aorta AIM
Validation Cohort

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥22 years of age) who underwent CT imaging of the aorta (whole, thoracic, or abdominal) as part of routine clinical care between January 1, 2016 and August 31, 2025. CT scans must include imaging of the aorta with or without contrast enhancement and have slice thickness ≤3mm. Patients with metal implants within 5cm of the aorta, prior aortic surgery, severe motion artifacts, congenital aortic anomalies, or post-traumatic aortic repairs are excluded. Patients who opted out of having their data used for medical research are also excluded. Retrospectively collected, de-identified CT imaging data from approximately 250 cases across multiple international sites in the United States and Latin America will be analyzed.

You may qualify if:

  • Adults ≥22 years at time of imaging
  • Studies performed 1 Jan 2016 - 31 August 2025
  • CT imaging of whole, thoracic, or abdominal aorta with or without contrast enhancement:
  • Non-contrast: cardiac-gated or non-gated
  • Contrast-enhanced: cardiac-gated thoracic and/or non gated abdominal
  • Slice thickness ≤ 3mm

You may not qualify if:

  • Metal implants \<5cm from aorta (e.g. thoracic stent)
  • Prior aortic surgery
  • Severe motion artifacts (e.g. \>3mm vessel blurring)
  • Congenital aortic anomalies (e.g. coarctation, vascular rings)
  • Post-traumatic aortic repairs
  • The patient opted out of having their data used for medical research before the date of cross-referencing by the site team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Innovation Health Services

Norfolk, Virginia, 23510, United States

Location

Hospital Israelita Albert Einstein

São Paulo, São Paulo, 05652-900, Brazil

Location

MeSH Terms

Conditions

Aortic AneurysmAortic Aneurysm, AbdominalAortic DissectionAortic Aneurysm, Thoracoabdominal

Condition Hierarchy (Ancestors)

AneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesDissection, Blood VesselAcute Aortic Syndrome

Study Officials

  • Jack Parker

    Aiatella Oy

    STUDY DIRECTOR
  • Scott Flamm

    SimonMed Imaging

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jack Parker

CONTACT

Scott Flamm, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

February 2, 2026

Primary Completion

July 30, 2026

Study Completion (Estimated)

September 5, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

This is a retrospective medical device validation study using de-identified CT imaging data. Individual participant data cannot be shared due to patient privacy protections, institutional data use agreements, and proprietary algorithm considerations. Aggregate study results, including device performance metrics and statistical analyses, will be made publicly available through peer-reviewed publication and regulatory submissions.

Locations